Accuray is a radiation oncology company that develops, manufactures, sells, and supports precise tumor treatment solutions. It delivers advanced treatments, including stereotactic radiosurgery, stereotactic body radiation therapy, intensity-modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. Its proprietary products, the CyberKnife, TomoTherapy, and Radixact systems are capable of treating all standard radiation therapy indications including breast, prostate, lung, and head and neck cancers. The company caters to the healthcare sector.